Point72 Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,524,485
| Closed | -$48.7M | – | 1474 |
|
2022
Q2 | $48.7M | Buy |
1,524,485
+604,285
| +66% | +$19.3M | 0.21% | 123 |
|
2022
Q1 | $31.9M | Buy |
920,200
+736,729
| +402% | +$25.5M | 0.13% | 195 |
|
2021
Q4 | $5.37M | Sell |
183,471
-2,129,129
| -92% | -$62.3M | 0.02% | 609 |
|
2021
Q3 | $58.9M | Buy |
2,312,600
+251,000
| +12% | +$6.4M | 0.26% | 78 |
|
2021
Q2 | $72.2M | Buy |
2,061,600
+736,118
| +56% | +$25.8M | 0.32% | 61 |
|
2021
Q1 | $54M | Buy |
1,325,482
+1,272,802
| +2,416% | +$51.9M | 0.25% | 91 |
|
2020
Q4 | $2.28M | Buy |
+52,680
| New | +$2.28M | 0.01% | 669 |
|
2020
Q3 | – | Sell |
-214,113
| Closed | -$13.5M | – | 1097 |
|
2020
Q2 | $13.5M | Sell |
214,113
-73,304
| -26% | -$4.63M | 0.09% | 264 |
|
2020
Q1 | $14.7M | Sell |
287,417
-177,264
| -38% | -$9.06M | 0.12% | 242 |
|
2019
Q4 | $36.9M | Sell |
464,681
-243,127
| -34% | -$19.3M | 0.19% | 146 |
|
2019
Q3 | $34.3M | Buy |
+707,808
| New | +$34.3M | 0.21% | 132 |
|
2018
Q3 | – | Sell |
-435,900
| Closed | -$19.7M | – | 1107 |
|
2018
Q2 | $19.7M | Buy |
+435,900
| New | +$19.7M | 0.08% | 239 |
|
2018
Q1 | – | Sell |
-226,300
| Closed | -$8.91M | – | 993 |
|
2017
Q4 | $8.91M | Sell |
226,300
-1,796,400
| -89% | -$70.7M | 0.04% | 384 |
|
2017
Q3 | $62.8M | Buy |
2,022,700
+1,323,934
| +189% | +$41.1M | 0.28% | 72 |
|
2017
Q2 | $19.1M | Buy |
698,766
+287,666
| +70% | +$7.87M | 0.11% | 218 |
|
2017
Q1 | $15.1M | Buy |
+411,100
| New | +$15.1M | 0.08% | 277 |
|
2016
Q2 | – | Sell |
-112,300
| Closed | -$1.78M | – | 835 |
|
2016
Q1 | $1.78M | Buy |
+112,300
| New | +$1.78M | 0.01% | 511 |
|